A new mathematical model for assessing therapeutic strategies for HIV infection

Abba Gumel, X. W. Zhang, P. N. Shivakumar, M. L. Garba, B. M. Sahai

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The requirements for the eradication of HIV in infected individuals are unknown. Intermittent administration of the immune activator interleukin-2 (IL-2) in combination with highly-active antiretroviral therapy (HAART) has been suggested as an effective strategy to realize long-term control of HIV replication in vivo. However, potential latent virus reservoirs are considered to be a major impediment in achieving this goal. In this paper, a new mathematical model is designed and used to monitor the interactions between HIV, CD4 + T-cells, CD8 + T-cells, productively infected and latently infected CD4+ T-cells, and to evaluate therapeutic strategies during the first 3 years of HIV infection. The model shows that current anti-HIV therapies, including intermittent IL-2 and HAART, are insufficient in achieving eradication of HIV. However, it suggests that the HIV eradication may indeed be theoretically feasible if such therapy is administered continuously (without interruption) under some specified conditions. These conditions may realistically be achieved using an agent (such as a putative anti-HIV vaccine) that brings about a concomitant increase in the proliferation of HIV-specific CD4 + T- and CD8 + T-cells and the differentiation of CD8 + T-cells into anti-HIV cytotoxic T lymphocytes (CTLs).

Original languageEnglish (US)
Pages (from-to)147-155
Number of pages9
JournalJournal of Theoretical Medicine
Volume4
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

HIV Infection
T-cells
HIV Infections
Theoretical Models
Therapy
HIV
Mathematical Model
Mathematical models
Interleukin
T-Lymphocytes
Interleukin-2
Highly Active Antiretroviral Therapy
Therapeutics
T Lymphocytes
Vaccine
AIDS Vaccines
Proliferation
Vaccines
Replication
Virus

Keywords

  • CTL
  • HAART
  • HIV
  • IL-2
  • Mathematical modeling

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

A new mathematical model for assessing therapeutic strategies for HIV infection. / Gumel, Abba; Zhang, X. W.; Shivakumar, P. N.; Garba, M. L.; Sahai, B. M.

In: Journal of Theoretical Medicine, Vol. 4, No. 2, 2002, p. 147-155.

Research output: Contribution to journalArticle

Gumel, Abba ; Zhang, X. W. ; Shivakumar, P. N. ; Garba, M. L. ; Sahai, B. M. / A new mathematical model for assessing therapeutic strategies for HIV infection. In: Journal of Theoretical Medicine. 2002 ; Vol. 4, No. 2. pp. 147-155.
@article{a45232a1f55b4ab49b3b70cf62b5a3dc,
title = "A new mathematical model for assessing therapeutic strategies for HIV infection",
abstract = "The requirements for the eradication of HIV in infected individuals are unknown. Intermittent administration of the immune activator interleukin-2 (IL-2) in combination with highly-active antiretroviral therapy (HAART) has been suggested as an effective strategy to realize long-term control of HIV replication in vivo. However, potential latent virus reservoirs are considered to be a major impediment in achieving this goal. In this paper, a new mathematical model is designed and used to monitor the interactions between HIV, CD4 + T-cells, CD8 + T-cells, productively infected and latently infected CD4+ T-cells, and to evaluate therapeutic strategies during the first 3 years of HIV infection. The model shows that current anti-HIV therapies, including intermittent IL-2 and HAART, are insufficient in achieving eradication of HIV. However, it suggests that the HIV eradication may indeed be theoretically feasible if such therapy is administered continuously (without interruption) under some specified conditions. These conditions may realistically be achieved using an agent (such as a putative anti-HIV vaccine) that brings about a concomitant increase in the proliferation of HIV-specific CD4 + T- and CD8 + T-cells and the differentiation of CD8 + T-cells into anti-HIV cytotoxic T lymphocytes (CTLs).",
keywords = "CTL, HAART, HIV, IL-2, Mathematical modeling",
author = "Abba Gumel and Zhang, {X. W.} and Shivakumar, {P. N.} and Garba, {M. L.} and Sahai, {B. M.}",
year = "2002",
doi = "10.1080/1027366021000003289",
language = "English (US)",
volume = "4",
pages = "147--155",
journal = "Computational and Mathematical Methods in Medicine",
issn = "1748-670X",
publisher = "Hindawi Publishing Corporation",
number = "2",

}

TY - JOUR

T1 - A new mathematical model for assessing therapeutic strategies for HIV infection

AU - Gumel, Abba

AU - Zhang, X. W.

AU - Shivakumar, P. N.

AU - Garba, M. L.

AU - Sahai, B. M.

PY - 2002

Y1 - 2002

N2 - The requirements for the eradication of HIV in infected individuals are unknown. Intermittent administration of the immune activator interleukin-2 (IL-2) in combination with highly-active antiretroviral therapy (HAART) has been suggested as an effective strategy to realize long-term control of HIV replication in vivo. However, potential latent virus reservoirs are considered to be a major impediment in achieving this goal. In this paper, a new mathematical model is designed and used to monitor the interactions between HIV, CD4 + T-cells, CD8 + T-cells, productively infected and latently infected CD4+ T-cells, and to evaluate therapeutic strategies during the first 3 years of HIV infection. The model shows that current anti-HIV therapies, including intermittent IL-2 and HAART, are insufficient in achieving eradication of HIV. However, it suggests that the HIV eradication may indeed be theoretically feasible if such therapy is administered continuously (without interruption) under some specified conditions. These conditions may realistically be achieved using an agent (such as a putative anti-HIV vaccine) that brings about a concomitant increase in the proliferation of HIV-specific CD4 + T- and CD8 + T-cells and the differentiation of CD8 + T-cells into anti-HIV cytotoxic T lymphocytes (CTLs).

AB - The requirements for the eradication of HIV in infected individuals are unknown. Intermittent administration of the immune activator interleukin-2 (IL-2) in combination with highly-active antiretroviral therapy (HAART) has been suggested as an effective strategy to realize long-term control of HIV replication in vivo. However, potential latent virus reservoirs are considered to be a major impediment in achieving this goal. In this paper, a new mathematical model is designed and used to monitor the interactions between HIV, CD4 + T-cells, CD8 + T-cells, productively infected and latently infected CD4+ T-cells, and to evaluate therapeutic strategies during the first 3 years of HIV infection. The model shows that current anti-HIV therapies, including intermittent IL-2 and HAART, are insufficient in achieving eradication of HIV. However, it suggests that the HIV eradication may indeed be theoretically feasible if such therapy is administered continuously (without interruption) under some specified conditions. These conditions may realistically be achieved using an agent (such as a putative anti-HIV vaccine) that brings about a concomitant increase in the proliferation of HIV-specific CD4 + T- and CD8 + T-cells and the differentiation of CD8 + T-cells into anti-HIV cytotoxic T lymphocytes (CTLs).

KW - CTL

KW - HAART

KW - HIV

KW - IL-2

KW - Mathematical modeling

UR - http://www.scopus.com/inward/record.url?scp=0036319885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036319885&partnerID=8YFLogxK

U2 - 10.1080/1027366021000003289

DO - 10.1080/1027366021000003289

M3 - Article

VL - 4

SP - 147

EP - 155

JO - Computational and Mathematical Methods in Medicine

JF - Computational and Mathematical Methods in Medicine

SN - 1748-670X

IS - 2

ER -